All filters
Abstracts
Absence of GS-6207 Phenotypic Resistance in HIV Gag Cleavage Site Mutants, Patient Isolates With Gag Polymorphisms, and Isolates With Resistance To Existing Drug Classes
C. Callebaut Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
Prevalence of transmitted resistance mutations to rilpivirine and doravirine in treatment-naive patients in a large clinical and resistance database
F. Lombardi  Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
Genotyping and treatment issues with unusual 1e and 1g HCV subtypes from African subjects: report of two cases.
C. Caudai Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
Susceptibility to bNAbs of transmitted HIV variants among recent infections in France
K. Stefic  Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
Baseline Hepatitis C Virus NS5A Resistance-Associated Polymorphisms in Patients with and without HIV coinfection in Mexico
B. Lopez Luis Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
Substantial clustered transmission of the acute hepatitis C among HIV co-infected men-who-have-sex-with-men (MSM)
D. Van De Vijver Reviews in Antiviral Therapy & Infectious Diseases 7, 2020  
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
Ibalizumab shows in vitro activity against group A and group B HIV-2 clinical isolates
Q. Le Hingrat  Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
Antiretroviral resistance in patients with multiple treatment failure in a low-middle income setting
J. Castillo-Álvarez  Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
Late presentation and HIV drug resistance in patients followed in Portugal between 1984-2017
M. Pingarilho Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
Prevalence and Correlates of Pre-Treatment HIV Drug Resistance among HIV-Infected in the Republic of Belarus
E. Gasich Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
Genetic characteristic of HIV-1 in patients with treatment failure in Kyrgyzstan in 2017-2018.
D. Saleeva Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
Case of detection of drug resistance mutations hepatitis C virus to the direct-acting antivirals
D. Valutite  Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
Prevalence of pretreatment HIV-1 drug resistance among treatment-naïve patients in the Russian Federation, 2014–2018
A. Kirichenko Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
The HBV treatment outcome to cART in HBV/HIV co-Infected patients who failed lamivudine containing regimens
G. Dragovic Lukic Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
Hepatotoxicity and the hepatic panel analysis among HIV-positive Ukrainian patients receiving efaverentz and dolutegravir-containing modes
A. Kiurdzhyieva Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
Feasibility and efficacy assessment of hepatitis B vaccination among adult PLWH and vulnerable population in Vinnytsia region, Ukraine
T. Melnyk Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
Natural course of hepatitis C virus infection: which factors affect spontaneous clearance of HCV among the Ukrainian population?
N. Zhandarova Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
Achieving the goals of the Fast-Track 90-90-90 strategy in the context of an anti-terrorist operation
M. Ovechkina Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
Effectiveness and tolerability of bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in HIV-1-infected adult patients in German routine clinical practice – 12-month results of the BICSTaR cohort
C. Stephan  Reviews in Antiviral Therapy & Infectious Diseases 7, 2020  
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Long-Acting Cabotegravir + Rilpivirine For HIV Treatment: Flair Week 96 Results
J. Jeffrey
Presented at:
European Meeting on HIV & Hepatitis 2020